These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 25856827)

  • 41. Correlation of indocyanine green angiography and optical coherence tomography findings after intravitreal ranibizumab for polypoidal choroidal vasculopathy.
    Ueno C; Gomi F; Sawa M; Nishida K
    Retina; 2012; 32(10):2006-13. PubMed ID: 22772392
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravitreal ranibizumab injections with and without pneumatic displacement for treating submacular hemorrhage secondary to neovascular age-related macular degeneration.
    Cho HJ; Koh KM; Kim JH; Kim HS; Han JI; Lew YJ; Lee TG; Kim JW
    Retina; 2015 Feb; 35(2):205-12. PubMed ID: 25105310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intravitreal injection of ziv-aflibercept in patient with refractory age-related macular degeneration.
    de Oliveira Dias JR; Xavier CO; Maia A; de Moraes NS; Meyer C; Farah ME; Rodrigues EB
    Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):91-4. PubMed ID: 25559518
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravitreal bevacizumab as primary treatment for retinal angiomatous proliferation: twelve-month results.
    Gharbiya M; Allievi F; Recupero V; Martini D; Mazzeo L; Gabrieli CB
    Retina; 2009 Jun; 29(6):740-9. PubMed ID: 19516116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration.
    Ach T; Hoeh AE; Ruppenstein M; Kretz FT; Dithmar S
    Retina; 2010 Oct; 30(9):1420-5. PubMed ID: 20543764
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravitreal bevacizumab versus ranibizumab for the treatment of retinal angiomatous proliferation.
    Parodi MB; Iacono P; Menchini F; Sheth S; Polini G; Pittino R; Bandello F
    Acta Ophthalmol; 2013 May; 91(3):267-73. PubMed ID: 21951313
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Submacular choroidal neovascularization at the margin of staphyloma in tilted disk syndrome.
    Furuta M; Iida T; Maruko I; Kishi S; Sekiryu T
    Retina; 2013 Jan; 33(1):71-6. PubMed ID: 23269406
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improvement in vision-related function with intravitreal aflibercept: data from phase 3 studies in wet age-related macular degeneration.
    Yuzawa M; Fujita K; Wittrup-Jensen KU; Norenberg C; Zeitz O; Adachi K; Wang EC; Heier J; Kaiser P; Chong V; Korobelnik JF
    Ophthalmology; 2015 Mar; 122(3):571-8. PubMed ID: 25439429
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections.
    Chan CK; Abraham P; Meyer CH; Kokame GT; Kaiser PK; Rauser ME; Gross JG; Nuthi AS; Lin SG; Daher NS
    Retina; 2010 Feb; 30(2):203-11. PubMed ID: 19952998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost comparison of intravitreal aflibercept with bevacizumab and ranibizumab for the treatment of wet age-related macular degeneration.
    Shaikh AH; Toussaint BW; Miller DM; Petersen MR; Foster RE; Riemann CD; Hutchins RK; Sisk RA
    Ophthalmic Surg Lasers Imaging Retina; 2015 Jan; 46(1):62-6. PubMed ID: 25559511
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optical coherence tomography-guided ranibizumab injection for cystoid macular edema in well-controlled uveitis: twelve-month outcomes.
    Reddy AK; Cabrera M; Yeh S; Davis JL; Albini TA
    Retina; 2014 Dec; 34(12):2431-8. PubMed ID: 25170857
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vitreomacular traction in a case of exudative age-related macular degeneration resistant to anti-VEGF therapy.
    Shah SU; Haller JA
    Acta Ophthalmol; 2012 Nov; 90(7):e569-70. PubMed ID: 22429537
    [No Abstract]   [Full Text] [Related]  

  • 53. Intravitreal ranibizumab injection for neovascular age-related macular degeneration in phakic versus pseudophakic eyes.
    Baek JS; Cho HJ; Cho SW; Kim CG; Kim JW
    Retina; 2013 Mar; 33(3):467-73. PubMed ID: 23400082
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microperimetric assessment of retinal sensitivity in eyes with diabetic macular edema from a phase 2 study of intravitreal aflibercept.
    Gonzalez VH; Boyer DS; Schmidt-Erfurth U; Heier JS; Gordon C; Benz MS; Marcus DM; Sabates NR; Vitti R; Kazmi H; Berliner AJ; Soo Y; Zhu X; Moini H; Zeitz O; Sandbrink R; Do DV
    Retina; 2015 Apr; 35(4):687-94. PubMed ID: 25621943
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intravitreal ranibizumab injection for idiopathic choroidal neovascularization in children.
    Kim R; Kim YC
    Semin Ophthalmol; 2014 May; 29(3):178-81. PubMed ID: 24491023
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study.
    Brown DM; Heier JS; Clark WL; Boyer DS; Vitti R; Berliner AJ; Zeitz O; Sandbrink R; Zhu X; Haller JA
    Am J Ophthalmol; 2013 Mar; 155(3):429-437.e7. PubMed ID: 23218699
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes.
    Puche N; Glacet A; Mimoun G; Zourdani A; Coscas G; Soubrane G
    Acta Ophthalmol; 2012 Jun; 90(4):357-61. PubMed ID: 20602625
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Aflibercept for the treatment of refractory polypoidal choroidal vasculopathy.
    Yonekawa Y
    Can J Ophthalmol; 2013 Jun; 48(3):e59-60. PubMed ID: 23769799
    [No Abstract]   [Full Text] [Related]  

  • 60. Three-year follow-up of a pilot study of ranibizumab combined with proton beam irradiation as treatment for exudative age-related macular degeneration.
    Park SS; Daftari I; Phillips T; Morse LS
    Retina; 2012 May; 32(5):956-66. PubMed ID: 22183743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.